NCT06439264

Brief Summary

The aim of this study is to evaluate osseous regeneration efficacy of bentonite gel with hydroxyapatite in comparison with hydroxyapatite incase of intrabony defects The test group includes patients with intrabony defects where flap surgery is will be performed and bentonite clay gel with HA will be placed and in control group only HA is placed.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 3, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

May 17, 2024

Completed
17 days until next milestone

First Posted

Study publicly available on registry

June 3, 2024

Completed
Last Updated

June 3, 2024

Status Verified

May 1, 2024

Enrollment Period

12 months

First QC Date

May 17, 2024

Last Update Submit

May 31, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • RVG

    1\. Radiovisiography will be used to assess bone regeneration achieved post operatively after 3 months and 6 months.

    baseline , 3months,6months

  • probing depth

    2\. Assessment of probing depth using probe at baseline and postoperatively at 3 and 6 months

    baseline , 3months,6months

  • clinical attachment level

    Assessment of clinical attachment level using probe at baseline and post operatively at 3 and 6 months.

    baseline , 3months,6months

Secondary Outcomes (1)

  • 1. Assessment of plaque - according to Turesky modification of Quigley and Hein Plaque Index, 1970. 2. Assessment of Gingivitis - according to Loe H and Silness P, 1963.

    baseline ,3months,6months

Study Arms (2)

test group

EXPERIMENTAL

In test group, after reflection of flap and degranulation, bone graft i.e., bentonite clay gel with hydroxyapatite will be placed in the void created by the defect and sutures will be placed

Other: bentonite clay gel with hydroxyapatite

control group

ACTIVE COMPARATOR

In control group, after reflection of flap and degranulation, bone graft i.e., hydroxyapatite will be placed in the defect and sutures will be placed.

Other: bentonite clay gel with hydroxyapatite

Interventions

bentonite clay gel presents great potential for bone healing and it leads to the formation of interconnected microporous structure, which can promote native cell infiltration, proliferation,

control grouptest group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Systemically healthy male and female patients of age \>18 years
  • two-walled or three-walled intrabony defects and
  • probing pocket depths (PPD) of ≥ 5mm.

You may not qualify if:

  • Medically compromised patients,
  • patients \<18 years of age,
  • pregnant women,
  • heavy smokers, and
  • patients who underwent radiotherapy or chemotherapy are excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Svs Dental College

Mahbūbnagar, Telangana, 509002, India

RECRUITING

MeSH Terms

Interventions

Durapatite

Intervention Hierarchy (Ancestors)

HydroxyapatitesApatitesCalcium PhosphatesPhosphatesPhosphoric AcidsPhosphorus AcidsAcids, NoncarboxylicAcidsInorganic ChemicalsCalcium CompoundsMineralsPhosphorus Compounds

Central Study Contacts

Dr.viswa chandra MDS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
PROFFESSOR AND HEAD OF THE DEPARTMENT

Study Record Dates

First Submitted

May 17, 2024

First Posted

June 3, 2024

Study Start

May 3, 2023

Primary Completion

May 1, 2024

Study Completion

May 1, 2024

Last Updated

June 3, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations